Simplex Trading
EVH icon

Simplex Trading’s Evolent Health EVH Stock Holding History

Simplex Trading’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.3K Buy
14,600
+12,500
+595% +$39.7K ﹤0.01% 6285
2025
Q4 		$8.4K Sell
2,100
-200
-9% -$1.11K ﹤0.01% 7098
2025
Q3 		$19K Sell
2,300
-15,700
-87% -$152K ﹤0.01% 7359
2025
Q2 		$202K Sell
18,000
-17,000
-49% -$156K ﹤0.01% 4492
2025
Q1 		$331K Sell
35,000
-30,100
-46% -$304K ﹤0.01% 3836
2024
Q4 		$732K Sell
65,100
-148,200
-69% -$2.6M ﹤0.01% 3159
2024
Q3 		$6.03M Buy
213,300
+198,100
+1,303% +$5.11M ﹤0.01% 1361
2024
Q2 		$290K Sell
15,200
-29,900
-66% -$764K ﹤0.01% 4274
2024
Q1 		$1.48M Buy
45,100
+27,700
+159% +$884K ﹤0.01% 2710
2023
Q4 		$574K Buy
17,400
+8,400
+93% +$238K ﹤0.01% 3544
2023
Q3 		$245K Buy
9,000
+6,600
+275% +$183K ﹤0.01% 4141
2023
Q2 		$72K Sell
2,400
-3,800
-61% -$123K ﹤0.01% 5455
2023
Q1 		$201K Buy
6,200
+5,600
+933% +$177K ﹤0.01% 4315
2022
Q4 		$16K Sell
600
-12,200
-95% -$350K ﹤0.01% 7075
2022
Q3 		$459K Buy
12,800
+10,700
+510% +$377K ﹤0.01% 3562
2022
Q2 		$64K Sell
2,100
-6,300
-75% -$184K ﹤0.01% 6166
2022
Q1 		$271K Sell
8,400
-11,500
-58% -$301K ﹤0.01% 4693
2021
Q4 		$550K Buy
19,900
+9,400
+90% +$270K ﹤0.01% 3662
2021
Q3 		$221K Hold
10,500
– – ﹤0.01% 5435
2021
Q2 		$221K Buy
+10,500
New +$210K ﹤0.01% 5529
2021
Q1 		– Sell
-211
Closed -$338K – 9119
2020
Q4 		$338K Sell
211
-120
-36% -$1.59K ﹤0.01% 3925
2020
Q3 		$410K Sell
331
-39
-11% -$459 ﹤0.01% 3234
2020
Q2 		$263K Buy
370
+101
+38% +$676 ﹤0.01% 3680
2020
Q1 		$146K Buy
269
+187
+228% +$1.67K ﹤0.01% 3949
2019
Q4 		$74K Sell
82
-165
-67% -$1.34K ﹤0.01% 4830
2019
Q3 		$177K Buy
247
+232
+1,547% +$1.67K ﹤0.01% 3693
2019
Q2 		$11K Sell
15
-57
-79% -$675 ﹤0.01% 6039
2019
Q1 		$90K Buy
72
+43
+148% +$681 ﹤0.01% 4452
2018
Q4 		$57K Sell
29
-291
-91% -$6.73K ﹤0.01% 4402
2018
Q3 		$908K Buy
320
+129
+68% +$3.08K ﹤0.01% 1992
2018
Q2 		$402K Buy
191
+13
+7% +$246 ﹤0.01% 2682
2018
Q1 		$49K Sell
178
-114
-39% -$1.63K ﹤0.01% 2460
2017
Q4 		$2K Buy
+292
New +$4.12K ﹤0.01% 5162
2017
Q2 		– Sell
-2
Closed -$1K – 6278
2017
Q1 		$1K Buy
+2
New +$38 ﹤0.01% 5612
2016
Q4 		– Sell
-2
Closed -$1K – 6001
2016
Q3 		$1K Buy
+2
New +$47 ﹤0.01% 5299

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's EVH Position: Q1 2026 in Review

Simplex Trading sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 47,159 shares — an estimated $150K sold.

Simplex Trading first reported a position in EVH in Q3 2016 and held it in 30 quarters. The position peaked at $2.72M in Q4 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Simplex Trading reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 47,159 Evolent Health shares in Q1 2026, an estimated $150K.
  • Simplex Trading first reported a position in Evolent Health in Q3 2016 and held it in 30 quarters.
  • Simplex Trading's Evolent Health position peaked at $2.72M in Q4 2023.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.